Browse studies

Find your next paid study

25,431 recruiting studies available now

Randomized Phase 2 Trial of Ruxolitinib in Combination With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma.

The purpose of this research is to test the safety and effectiveness of the investigational drug ruxolitinib when it is combined with standard of care treatmen…

GlioblastomaBrain CancerGlioblastoma Multiforme+4 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Baptist Health South FloridaNCT06991101

Breathing Patterns in Infants Before and After Extubation

The primary objective of this study is to compare work of breathing indices before and after extubation in intubated premature infants admitted to the Christia…

Respiratory Distress Syndrome (RDS)PreTerm Neonate

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Christiana Care Health ServicesNCT07542301

Observational

The Ohio State University Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) Project

This clinical trial tests the impact of the The Ohio State University Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) project on clinical …

Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm

Estimated

~$10 – $750

Actual pay is set by the research site.

Ohio State University Comprehensive Cancer CenterNCT06314672

Observational

The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS): A Pragmatic Trial of Precision Prostate Cancer Screening

Prostate cancer is the most common non-skin cancer among Veterans and the second leading cause of male cancer death. Current methods of screening men for prost…

Prostate Cancer

Estimated

~$10 – $675

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT05926102

Phase 4

The Effects of Orexin Antagonism on Fear Extinction in PTSD

PTSD affects approximately 22% of Veterans who have served in Iraq and Afghanistan. Symptoms of PTSD may include re-experiencing, avoidance of trauma reminders…

InsomniaPTSD

Estimated

~$25 – $900

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT06788522

Phase 1

A Phase 1a/b Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19

This first-in-human study is designed to evaluate the safety, tolerability, pharmacokinetics, anti-drug antibodies, and neutralizing activity of MDX2301 admini…

COVID -19COVID-19 (Prevention)

Estimated

~$500 – $10,500

Actual pay is set by the research site.

ModeX Therapeutics, An OPKO Health CompanyNCT07445971

Observational

Emotional Brain Training for Addiction Medicine Treatment - A Pilot Study

The goal of this clinical trial is to determine whether Emotional Brain Training (EBT), a behavioral modification method, can help manage stress and health pro…

Cannabis Use DisorderStimulant Use DisorderOpioid Use Disorder+3 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Loma Linda UniversityNCT07001371

Observational

Accuracy and Effect of Prescribed Generative AI Patient Education Module Within Breast Oncology Care

This study evaluates the safety, accuracy, and impact of an artificial intelligence (AI) tool designed to support patient education in breast cancer care for b…

Breast CancerMetastatic Breast CancerCarcinoma of the Breast

Estimated

~$10 – $675

Actual pay is set by the research site.

University of California, San FranciscoNCT07512271

Observational

Reducing Crises and Suicide Within the Idaho Army National Guard - Enhancement of the First Line Leader Program

Military suicide is an ongoing public health concern, particularly within the Army National Guard (ARNG), with longstanding effects on fellow soldiers, family,…

Crisis Response PlanCrisis Intervention

Estimated

~$10 – $750

Actual pay is set by the research site.

University of RochesterNCT07032636

Phase 2

A Multicenter, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Venetoclax-Obinutuzumab Retreatment in Patients With Recurring Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia (CLL) is the most common leukemia (cancer of blood cells). The purpose of this study is to assess retreatment with venetoclax-obin…

Chronic Lymphocytic Leukemia (CLL)

Estimated

~$75 – $3,000

Actual pay is set by the research site.

AbbVieNCT04895436

Phase 2

Optimizing Reperfusion to Improve Outcomes and Neurologic Function (ORION): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Phase 2/3 Study to Evaluate the Efficacy and Safety of JX10 in Acute Ischemic Stroke With Late Presentations

The goal of this study is to evaluate the safety and efficacy of JX10 versus placebo in participants with Acute Ischemic Stroke (AIS) who present for care with…

Acute Ischemic Stroke

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Corxel PharmaceuticalsNCT06990867

Phase 1

A Pilot Study of Duffy Null-Specific Dose Modifications for Individuals With Duffy Null Phenotype Receiving Standard of Care Systemic Anti-Cancer Therapies

This study is comprised of a main study, an observational study, and optional survey studies. The main study is being done to see whether using Duffy null spec…

Multiple MyelomaTriple Negative Breast CancerDuffy Blood Group, Chemokine Receptor Gene Mutation+1 more

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Andrew Hantel, MDNCT07341867